Where can I buy the therapeutic antibody of MAb425?

A new study says that the experimental drug MAb 425 may help patients with brain tumors to prolong their life.

From 65438 to 0995, researchers reported that this antibody called MAb 425 could prolong the survival time of patients with brain tumors. With further research, experts now report that patients with brain tumors live longer than expected after being treated with this drug. However, Rodeck, one of the scientists involved in the drug development, warned that this conclusion should be correctly understood. "We have come to the conclusion that it is promising, but it cannot be used to prove its effectiveness," said Thomas Jefferson University in Philadelphia, USA. "This is a good start, but we need to be cautious."

Published in American Journal of Clinical Oncology (2002; 25:54 1-546), this new study was led by Lu Se w Brady of drexel university school of medicine in Philadelphia. The subjects are 180 brain tumor patients who have been treated since 1987, all of whom have received surgery or radiotherapy, and some of them have also received chemotherapy.

Patients with brain cancer usually die within one or two years after diagnosis. In this study, the average survival time of patients with glioblastoma multiforme was over 13 months, but the researchers thought that one outstanding achievement was that 10 of them survived for more than 5 years after diagnosis. In addition, the average survival time of patients with astrocytoma is more than 4 years.

Big hospitals should have them. .

I wish you all the best, good health, icing on the cake and all the best.